1-3 of 3
Ravi K. Paluri, MD
Close
Sort by
Journal Articles

A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

Omer Jamy, MD, Racquel Innis-Shelton, MD, Susan Bal, MDMBBS, Ravi K. Paluri, MD, Samina Karim, Joseph H. Chewning, MD, Donna Salzman, MD, Luciano J. Costa, MD PhD, Antonio Di Stasi, MD, Lawrence S. Lamb, Jr., PhD, Shin Mineishi, Ayman Saad, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2003.
https://doi.org/10.1182/blood-2019-129536
Published: 2019
Journal Articles

Favorable Immune Reconstitution Profile after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Omer Hassan Jamy, MD, Ayman Saad, MD, Rachael Orlandella, BS, Samantha B Langford, BS, Ravi K. Paluri, MD, Racquel Innis-Shelton, MD, Shin Mineishi, MD, Lawrence S. Lamb, Jr., PhD
Journal: Blood
Blood (2016) 128 (22): 2236.
https://doi.org/10.1182/blood.V128.22.2236.2236
Published: 2016
Journal Articles

Influence of Pre-Transplant Cytomegalovirus (CMV) Serostatus on Post-Transplant Viral Reactivation after Allogeneic Stem Cell Transplantation in Patients Receiving Post-Transplant Cyclophosphamide for Gvhd Prophylaxis

Ravi K. Paluri, MD, Racquel Shelton, Melissa Gazi, Lawrence S. Lamb, PhD, Ayman Saad, MD, Donna Salzman, MD, Antonio Di Stasi, MD, Shin Mineishi, MD
Journal: Blood
Blood (2014) 124 (21): 3864.
https://doi.org/10.1182/blood.V124.21.3864.3864
Published: 2014